Capital Growth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-420,000
Closed -$43.3M 58
2021
Q4
$43.3M Buy
420,000
+95,000
+29% +$8.78M 3.98% 2
2021
Q3
$27.6M Buy
+325,000
New +$27.2M 2.53% 11

Other funds holding CVS

Capital Growth Management's CVS Position: Q1 2022 in Review

Capital Growth Management sold out of CVS Health (CVS) in Q1 2022, closing a stake of 420,000 shares — an estimated $43.3M sold.

Capital Growth Management first reported a position in CVS in Q3 2021 and held it in 2 quarters. The position peaked at $43.3M in Q4 2021. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • Capital Growth Management reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
  • Capital Growth Management sold 420,000 CVS Health shares in Q1 2022, an estimated $43.3M.
  • Capital Growth Management first reported a position in CVS Health in Q3 2021 and held it in 2 quarters.
  • Capital Growth Management's CVS Health position peaked at $43.3M in Q4 2021.
  • 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Capital Growth Management's 13F filing for Q1 2022, filed 13 May 2022.